
thumb|right|75px|Xocova in a Japanese blister pack
via Wikipedia infobox
thumb|right|75px|Xocova in a Japanese blister pack
Ensitrelvir, sold under the brand name Xocova is an antiviral medication used as a treatment for COVID-19. It was developed by Shionogi in partnership with Hokkaido University and acts as an orally active 3C-like protease inhibitor. It is taken by mouth.
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).